Mersana Therapeutics, Inc. Contract Liability (Deferred Revenue)
Mersana Therapeutics, Inc. had Contract Liability (Deferred Revenue) of $23.77 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2025-11-14
- 2025-09-30: Contract with Customer, Liability, Current $23.77M.
- 2025-06-30: Contract with Customer, Liability, Current $20.18M.
- 2025-03-31: Contract with Customer, Liability, Current $23.71M.
- 2024-12-31: Contract with Customer, Liability, Current $22.17M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2025-09-30 | $23.77M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $20.18M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $23.71M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $22.17M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $31.37M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $29.34M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $25.62M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $28.15M 10-K · filed 2025-03-03 |
| 2023-09-30 | $21.59M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $20.50M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $28.77M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $30.61M 10-K · filed 2024-02-28 |
| 2022-09-30 | $30.92M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $26.23M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $16.58M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $3.94M 10-K · filed 2023-02-28 |
| 2021-09-30 | $3.96M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $3.97M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $3.98M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $3.99M 10-K · filed 2022-02-28 |
| 2020-09-30 | $4.00M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $4.01M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $4.80M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $4.82M 10-K · filed 2021-02-26 |
| 2019-09-30 | $4.65M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $5.48M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $5.60M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $46.20M 10-K · filed 2020-02-28 |
| 2018-09-30 | $14.15M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $19.22M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $20.90M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $21.64M 10-K · filed 2019-03-08 |